Bringing the fundamentals into focus…
Back to Fennec Pharmaceuticals Inc.
How Fennec Pharmaceuticals Inc. stacks up
FENC · against 351 other Healthcare companies of similar size
Growth
94/ 100
Near the top of its peers.
Ranked #19 of 352 · scores higher than 94% of peers
Bars: peers in each 10-point band of the growth score33 peers with a growth score of 90–100, including FENC · Click a bar to see the companies
Why growth scores 94?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 93% of peers. Revenue growth: 77.8% vs peer median 6.1%
- faster revenue growth over three years: stronger than 98% of peers. 3-year revenue growth: 207.5% vs peer median 5.8%
Metric by metric
Position: dot = FENC, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | FENC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 366 reported | 77.8% | 2.5% | 93% | 33% | |
| Earnings per share growthHigher is better · 174 reported | Not reported | 2.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 345 reported | 207.5% | 3.2% | 97% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around FENC| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 2 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 609M USD | 99 | 91 | |
| 16 | 274M USD | 95 | 57 | |
| 16 | 467M USD | 95 | 44 | |
| 19 | 13.0B TWD (≈$402M) | 94 | 49 | |
| 19 | 257M USD | 94 | 55 | |
| 19 | 375M USD | 94 | 46 | |
| 19 | 20.8B THB (≈$581M) | 94 | 63 | |
| 19 | 393M USD | 94 | 61 | |
| 24 | 387M USD | 93 | 49 | |
| 25 | 287.6B KRW (≈$207M) | 92 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score